Document is current
Any future updates will be listed below
-
Authors
Black, James R. M. https://orcid.org/0000-0001-5598-7752
Bartha, Gabor
Abbott, Charles W.
Boyle, Sean M. https://orcid.org/0000-0002-4402-8449
Karasaki, Takahiro https://orcid.org/0000-0001-6863-2360
Li, Bailiang https://orcid.org/0000-0001-6729-219X
Chen, Rui https://orcid.org/0000-0001-7789-0978
Harris, Jason
Veeriah, Selvaraju
Colopi, Martina
Bakir, Maise Al https://orcid.org/0000-0002-0846-8332
Liu, Wing Kin
Lyle, John
Navarro, Fábio C. P. https://orcid.org/0000-0002-5640-9070
Northcott, Josette
Pyke, Rachel Marty
Hill, Mark S. https://orcid.org/0000-0003-0718-8934
Thol, Kerstin
Huebner, Ariana
Bailey, Chris
Colliver, Emma C. https://orcid.org/0000-0002-1497-0740
Martínez-Ruiz, Carlos https://orcid.org/0000-0002-4817-0565
Grigoriadis, Kristiana https://orcid.org/0000-0002-8435-0176
Pawlik, Piotr
Moore, David A.
Marinelli, Daniele https://orcid.org/0000-0002-6002-363X
Shutkever, Oliver G.
Murphy, Cian https://orcid.org/0000-0003-1356-959X
Sivakumar, Monica
,
Lester, Jason F.
Bajaj, Amrita
Nakas, Apostolos
Sodha-Ramdeen, Azmina
Tufail, Mohamad
Scotland, Molly
Boyles, Rebecca
Rathinam, Sridhar
Wilson, Claire
Marrone, Domenic
Dulloo, Sean
Fennell, Dean A.
Matharu, Gurdeep
Boleti, Ekaterini
Cheyne, Heather
Khalil, Mohammed
Richardson, Shirley
Cruickshank, Tracey
Price, Gillian
Kerr, Keith M.
Benafif, Sarah
French, Jack
Gilbert, Kayleigh
Naidu, Babu
Patel, Akshay J.
Osman, Aya
Enstone, Carol
Langman, Gerald
Shackleford, Helen
Djearaman, Madava
Kadiri, Salma
Middleton, Gary
Leek, Angela
Hodgkinson, Jack Davies
Totton, Nicola
Montero, Angeles
Smith, Elaine
Fontaine, Eustace
Granato, Felice
Paiva-Correia, Antonio
Novasio, Juliette
Rammohan, Kendadai
Joseph, Leena
Bishop, Paul
Shah, Rajesh
Moss, Stuart
Joshi, Vijay
Crosbie, Philip A. J.
Brown, Katherine D.
Carter, Mathew
Chaturvedi, Anshuman
Oliveira, Pedro
Lindsay, Colin R.
Blackhall, Fiona H.
Krebs, Matthew G.
Summers, Yvonne
Clipson, Alexandra
Tugwood, Jonathan
Kerr, Alastair
Rothwell, Dominic G.
Dive, Caroline
Aerts, Hugo JWL
Schwarz, Roland F.
Kaufmann, Tom L.
Wilson, Gareth A.
Rosenthal, Rachel
Van Loo, Peter
Birkbak, Nicolai J.
Szallasi, Zoltan
Kisistok, Judit
Sokac, Mateo
Salgado, Roberto
Diossy, Miklos
Demeulemeester, Jonas
Bunkum, Abigail
Dwornik, Angela
Magness, Alastair
Rowan, Andrew J.
Karamani, Angeliki
Toncheva, Antonia
Chain, Benny
Castignani, Carla
Abbosh, Christopher
Puttick, Clare
Weeden, Clare E.
Lee, Claudia
Richard, Corentin
Hiley, Crispin T.
Naceur-Lombardelli, Cristina
Pearce, David R.
Karagianni, Despoina
Biswas, Dhruva
Levi, Dina
Cadieux, Elizabeth Larose
Lim, Emilia L.
Nye, Emma
Grönroos, Eva
Gálvez-Cancino, Felip
Gimeno-Valiente, Francisco
Kassiotis, George
Stavrou, Georgia
Mastrokalos, Gerasimos-Theodoros
Lowe, Helen L.
Matos, Ignacio Garcia
Noorani, Imran
Goldman, Jacki
Reading, James L.
Rane, Jayant K.
Nicod, Jerome
Hartley, John A.
Peggs, Karl S.
Enfield, Katey S. S.
Selvaraju, Kayalvizhi
Litchfield, Kevin
Ng, Kevin W.
Chen, Kezhong
Dijkstra, Krijn
Thakkar, Krupa
Ensell, Leah
Shah, Mansi
Litovchenko, Maria
Sunderland, Mariana Werner
Huska, Matthew R.
Dietzen, Michelle
Leung, Michelle M.
Escudero, Mickael
Angelova, Mihaela
Tanić, Miljana
Kanu, Nnennaya
Chervova, Olga
Lucas, Olivia
Pich, Oriol
Al-Sawaf, Othman
Prymas, Paulina
Hobson, Philip
Stone, Richard Kevin
Bentham, Robert
Hynds, Robert E.
Vendramin, Roberto
Saghafinia, Sadegh
Gamble, Samuel
Ung, Seng Kuong Anakin
Quezada, Sergio A.
Vanloo, Sharon
Zaccaria, Simone
Hessey, Sonya
Ward, Sophia
Harries, Sian
Boeing, Stefan
Beck, Stephan
Bola, Supreet Kaur
Denner, Tamara
Marafioti, Teresa
Watkins, Thomas B. K.
Jones, Thomas Patrick
Spanswick, Victoria
Barbè, Vittorio
Lu, Wei-Ting
Hill, William
Wu, Yin
Naito, Yutaka
Ramsden, Zoe
Veiga, Catarina
Royle, Gary
Collins-Fekete, Charles-Antoine
Fraioli, Francesco
Ashford, Paul
Forster, Martin D.
Lee, Siow Ming
Borg, Elaine
Falzon, Mary
Papadatos-Pastos, Dionysis
Wilson, James
Ahmad, Tanya
Procter, Alexander James
Ahmed, Asia
Taylor, Magali N.
Nair, Arjun
Lawrence, David
Patrini, Davide
Navani, Neal
Thakrar, Ricky M.
Janes, Sam M.
Hoogenboom, Emilie Martinoni
Monk, Fleur
Holding, James W.
Choudhary, Junaid
Bhakhri, Kunal
Scarci, Marco
Gorman, Pat
Khiroya, Reena
Stephens, Robert CM
Wong, Yien Ning Sophia
Kaplar, Zoltan
Bandula, Steve
Hacker, Anne-Marie
Sharp, Abigail
Smith, Sean
Dhanda, Harjot Kaur
Pilotti, Camilla
Leslie, Rachel
Grapa, Anca
Zhang, Hanyun
AbdulJabbar, Khalid
Pan, Xiaoxi
Yuan, Yinyin
Chuter, David
MacKenzie, Mairead
Chee, Serena
Alzetani, Aiman
Cave, Judith
Richards, Jennifer
Lim, Eric
De Sousa, Paulo
Jordan, Simon
Rice, Alexandra
Raubenheimer, Hilgardt
Bhayani, Harshil
Ambrose, Lyn
Devaraj, Anand
Chavan, Hema
Begum, Sofina
Buderi, Silviu I.
Kaniu, Daniel
Malima, Mpho
Booth, Sarah
Nicholson, Andrew G.
Fernandes, Nadia
Shah, Pratibha
Proli, Chiara
Hewish, Madeleine
Danson, Sarah
Shackcloth, Michael J.
Robinson, Lily
Russell, Peter
Blyth, Kevin G.
Kidd, Andrew
Dick, Craig
Le Quesne, John
Kirk, Alan
Asif, Mo
Bilancia, Rocco
Kostoulas, Nikos
Thomas, Mathew
Shaw, Jacqui A.
Hackshaw, Allan https://orcid.org/0000-0002-5570-5070
McGranahan, Nicholas https://orcid.org/0000-0001-9537-4045
Jamal-Hanjani, Mariam https://orcid.org/0000-0003-1212-1259
Frankell, Alexander M. https://orcid.org/0000-0002-0341-7878
Chen, Richard O. https://orcid.org/0000-0002-2842-4476
Swanton, Charles https://orcid.org/0000-0002-4299-3018
- License Information
-
More Information
Article History
Received: 21 September 2023
Accepted: 29 July 2024
First Online: 13 January 2025
Competing interests
: M.A.B. has consulted for Achilles Therapeutics. D.A.M. reports receiving speaker fees from AstraZeneca, Eli Lilly, Bristol Myers Squibb and Takeda, consultancy fees from AstraZeneca, Thermo Fisher, Takeda, Amgen, Janssen, MIM Software, Bristol Myers Squibb and Eli Lilly and has received educational support from Takeda and Amgen. M.J.-H. has consulted for, and is a member of, the Achilles Therapeutics scientific advisory board (SAB) and steering committee, and has received speaker honoraria from Pfizer, Astex Pharmaceuticals and the Oslo Cancer Cluster. N.M. has received consultancy fees and has stock options in Achilles Therapeutics. C.S. acknowledges grants from AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Pfizer, Roche-Ventana, Invitae (previously Archer Dx Inc, collaboration in minimal residual disease sequencing technologies), Ono Pharmaceutical and Personalis. He is chief investigator for the AZ MeRmaiD 1 and 2 clinical trials and is the steering committee chair. He is also co-chief investigator of the NHS Galleri trial funded by GRAIL and a paid member of GRAIL’s SAB. He receives consultant fees from Achilles Therapeutics (and is a SAB member), Bicycle Therapeutics (and is a SAB member), Genentech, Medicxi, China Innovation Centre of Roche (formerly Roche Innovation Centre – Shanghai, Metabomed (until July 2022)), Relay Therapeutics (and is a SAB member), Saga Diagnostics (and is a SAB member) and the Sarah Cannon Research Institute. C.S has received honoraria from Amgen, AstraZeneca, Bristol Myers Squibb, GSK, Illumina, MSD, Novartis, Pfizer and Roche-Ventana. C.S. has previously held stock options in Apogen Biotechnologies and GRAIL, and currently has stock options in Bicycle Therapeutics and Relay Therapeutics, and has stock and is a co-founder of Achilles Therapeutics. G.B., C.W.A., S.M.B, R.C., J.H., B.L., J.L., F.C.P.N., J.N., R.M.P. and R.O.C. are employees and stockholders of Personalis. A.M.F. is listed as a co-inventor on a patent application to determine methods and systems for tumor monitoring (PCT/EP2022/077987; ‘Methods and systems for tumour monitoring’). S.V. is a co-inventor on a patent for methods for detecting molecules in a sample (US patent no. 10578620; ‘Methods for detecting molecules in a sample’). M.J.-H. is listed as a co-inventor on a European patent application related to methods to detect lung cancer (PCT/US2017/028013; ‘Methods for lung cancer detection’); this patent has been licensed to commercial entities and, under terms of employment, M.J.-H. is due a share of any revenue generated from such license(s). N.M. holds European patents related to targeting neoantigens (PCT/EP2016/059401; ‘Method for treating cancer’), identifying patient response to immune checkpoint blockade (PCT/EP2016/071471; ‘“Immune checkpoint intervention” in cancer’), determining HLA LOH (PCT/GB2018/052004; ‘Analysis of HLA alleles in tumours and the uses thereof’), and predicting survival rates of patients with cancer (PCT/GB2020/050221; ‘Method of predicting survival rates for cancer patients’). C.S declares a patent application for methods to lung cancer (PCT/US2017/028013); targeting neoantigens (PCT/EP2016/059401); identifying patent response to immune checkpoint blockade (PCT/EP2016/071471); methods for lung cancer detection (US20190106751A1); identifying patients who respond to cancer treatment (PCT/GB2018/051912); determining HLA LOH (PCT/GB2018/052004); predicting survival rates of patients with cancer (PCT/GB2020/050221); and methods and systems for tumor monitoring (PCT/EP2022/077987). C.S. is an inventor on a European patent application (PCT/GB2017/053289) related to assay technology to detect tumor recurrence. This patent has been licensed to a commercial entity, and under their terms of employment, C.S is due a revenue share of any revenue generated from such license(s). The other authors declare no competing interests.
